Therapeutical Approach of Osteoporosis — a Multidisciplinary Issue

1. Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467-75.10.1016/j.bone.2007.11.00118180210Search in Google Scholar

2. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Available at http://www.nof.org/professionals/ clinical-guidelines. 2011Search in Google Scholar

3. Bono CM, Einhorn TA. Overview of osteoporosis: pathophysiology and determinants of bone strength. Eur Spine J. 2003;12(2):90-6.Search in Google Scholar

4. Ringe JD, Farahmand P. Advances in the management of corticosteroidinduced osteoporosis with bisphosphonates. Clin Rheumatol. 2007;26(4):474-84.10.1007/s10067-006-0467-z17122953Search in Google Scholar

5. Raisz LG. Pathogenesis of osteoporosis: concepts, confl icts, and prospects. J Clin Invest. 2005;115(12):3318-25.10.1172/JCI27071129726416322775Search in Google Scholar

6. http://www.shef.ac.uk/FRAXSearch in Google Scholar

7. Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184-92.10.1001/jama.2011.715328738921632482Search in Google Scholar

8. Lecart MP, Reginster JY. Current options for the management of postmenopausal osteoporosis. Expert Opin Pharmacother. 2011;12(16): 2533-52.10.1517/14656566.2011.61812321916810Search in Google Scholar

9. Sandhu SK, Hampson G. The pathogenesis, diagnosis, investigation and management of osteoporosis. J Clin Pathol. 2011;64(12):1042-50.10.1136/jcp.2010.07784221896577Search in Google Scholar

10. World Health Organization. WHO scientifi c group on the assessment of osteoporosis at primary health care level: summary meeting report. Available at http://www.who.int/chp/topics/Osteoporosis.pdf. 2012.Search in Google Scholar

11. Silverman SL. Selecting patients for osteoporosis therapy. Ann N Y Acad Sci. 2007;1117:264-72.10.1196/annals.1402.04218056046Search in Google Scholar

12. Warensjö E, Byberg L, Melhus H, et al. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ. 2011;342: d1473.10.1136/bmj.d1473310133121610048Search in Google Scholar

13. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(6):551-61.10.1001/archinternmed.2008.60019307517Search in Google Scholar

14. Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010;16(3):1-37.10.4158/EP.16.S3.1Search in Google Scholar

15. Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006;355:125-37.10.1056/NEJMoa06246216837676Search in Google Scholar

16. Geusens P. Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. Curr Osteoporos Rep 2009, 7 (1):12-7.10.1007/s11914-009-0003-619239824Search in Google Scholar

17. National Osteoporosis Foundation. Fast facts. Available at http://www.nof.org/node/40. 2012.Search in Google Scholar

18. McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354(8):821-31.10.1056/NEJMoa04445916495394Search in Google Scholar

19. Blake GM, Fogelman I. Long-term effect of strontium ranelate treatment on BMD. J Bone Miner Res. 2005;20(11):1901-4. 10.1359/JBMR.05081016234961Search in Google Scholar